EDGAR Filing Documents for 0001193125-17-370765

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-370765

Filing Date

2017-12-15

Accepted

2017-12-15 16:22:00

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d475184ds3.htm	S-3	368734
2	EX-1.2	d475184dex12.htm	EX-1.2	163028
3	EX-4.1	d475184dex41.htm	EX-4.1	314055
4	EX-4.2	d475184dex42.htm	EX-4.2	343909
5	EX-4.3	d475184dex43.htm	EX-4.3	39537
6	EX-4.4	d475184dex44.htm	EX-4.4	42595
7	EX-5.1	d475184dex51.htm	EX-5.1	36511
8	EX-12.1	d475184dex121.htm	EX-12.1	25885
9	EX-21.1	d475184dex211.htm	EX-21.1	1912
10	EX-23.1	d475184dex231.htm	EX-23.1	1967
11	GRAPHIC	g475184g1215103816791.jpg	GRAPHIC	1649
12	GRAPHIC	g475184g1215104112508.jpg	GRAPHIC	1565
	Complete submission text file	0001193125-17-370765.txt		1343878

Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000

MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)